- 1. PUR Alpha
- [This gene product is a sequence-specific, single-stranded DNA-binding protein. It binds preferentially to the single strand of the purine-rich element termed PUR, which is present at origins of replication and in gene flanking regions in a variety of eukaryotes from yeasts through humans. Thus, it is implicated in the control of both DNA replication and transcription. Deletion of the gene has been associated with myelodysplastic syndrome and acute myelogenous leukemia. (from LocusLink) ( NCI )] (UMLS (NCI) C0291181) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 17. Purine Metabolism
- (UMLS (NCI) C0920640) Purine Metabolism Pathway =Functional Concept ;
|
- 2. PURA
- [This gene plays a regulatory role in DNA replication and transcription. ( NCI )] (UMLS (NCI) C1335290) PURA Gene;
Purine-Rich Element Binding Protein A Gene =Gene or Genome ;
| - 18. purine metabolism disorder
- [ ] (UMLS (CSP) C0268104) =Disease or Syndrome ;
|
- 3. Purdue Pegboard Test
- [The Purdue Pegboard test measures finger dexterity and hand-eye coordination by testing an individual's ability to move hands, fingers, and arms (gross motor movement) and to control movements of small objects (fingertip dexterity). Measurements of the right hand, left hand, and both hands are part of the test. ( NCI )] (UMLS (NCI) C0204462) =Diagnostic Procedure
| - 19. purine nucleoside
- [condensation product of a purine base plus a sugar. ( CSP )] (UMLS (CSP) C0034136) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
=nucleoside;
=inosine;
adenine nucleoside;
guanine nucleoside;
adenosine;
inosine;
|
- 4. Pure Erythroid Leukemia in Remission
- [Pure erythroid leukemia that is responding to therapy, i.e. It is not progressing and possibly regressing. ( NCI )] (UMLS (NCI) C1335577) =Neoplastic Process ;
| - 20. purine nucleotide
- [phosphate ester of a purine nucleoside, particularly the 5' phosphate of a purine in N-glycosidic linkage with ribose or deoxyribose as occurs in nucleic acid. ( CSP )] (UMLS (CSP) C0034137) =Nucleic Acid, Nucleoside, or Nucleotide =nucleotide;
=adenine nucleotide;
guanine nucleotide;
IMP;
adenine nucleotide |
- 5. PURE HYPERCHOLESTEROLEM
- (UMLS (ICD9CM) C0678189) =Disease or Syndrome ;
| - 21. purine riboside
- [ ] (UMLS (CSP) C0068476) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
|
- 6. pure line
- [ ] (UMLS (CSP) C0599804) =Organism ;
| - 22. Purine-Nucleoside Phosphorylase Deficiency
- [PNP reversibly catalyzes the phosphorolysis of the purine nucleosides, (deoxy)inosine and (deoxy)guanosine, to their respective purine bases and the corresponding ribose-1-phosphate. Deficiency in this enzyme is an autosomal recessive cause of combined immunodeficiency. ( NCI )] (UMLS (NCI) C0268125) =Disease or Syndrome ;
|
- 7. Pure Red Cell Aplasia
- [Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production. ( MSH )] (UMLS (NCI) C0034902) =Disease or Syndrome =anemia;
| - 23. purine/pyrimidine metabolism
- [sum of chemical changes that occur within the tissues of an organism consisting of anabolism (biosynthesis) and catabolism of purines or pyrimidines; the buildup and breakdown of purines or pyrimidines for utilization by the organism. ( CSP )] (UMLS (CSP) C0597326) =Molecular Function ;
=Intermediary Metabolism;
|
- 8. Pure Sideroblastic Anemia
- [A myelodysplastic syndrome characterized by an anemia in which 15% or more of the erythroid precursors are ringed sideroblasts. The ring sideroblast is an erythroid precursor in which one third or more of the nucleus is encircled by granules which are positive for iron stain. It occurs primarily in older individuals. The median survival exceeds 5 years. (WHO, 2001) ( NCI )] (UMLS (NCI) C1264195) RARS;
Refractory Anemia with Ringed Sideroblasts;
=Neoplastic Process | - 24. purine/pyrimidine metabolism disorder
- [condition in which there is a deviation or interruption in the processing of purine or pyrmidine in the body: its absorption, transport, storage, and utilization. ( CSP )] (UMLS (CSP) C0034139) =Disease or Syndrome =Congenital Metabolic Disorder;
=Gicht;
hypoxanthine guanine phosphoribosyltransferase deficiency;
orotate phosphoribosyltransferase deficiency;
Gicht;
hypoxanthine guanine phosphoribosyltransferase deficiency;
|
- 9. Purge Status Code
- (UMLS (HL7) C1547622) =Intellectual Product =HL7 Vocabulary Version 2.5;
=The visit is marked for deletion and the user cannot enter new data against it.;
The visit is marked inactive and the user cannot enter new data against it.;
Marked for purge. User is no longer able to update the visit. | - 25. Purinergic Receptor
- [any molecular receptor for adenine, guanine, or other purine, or their nucleosides or nucleotides, including cyclic nucleotides other than cAMP (see NT); adenine and ATP are important neurotransmitters, so their receptors are found in neural synapses, among other sites. ( CSP )] (UMLS (NCI) C0034836) =Amino Acid, Peptide, or Protein; Receptor =Cell Surface Receptor;
=cyclic AMP receptor |
- 10. Purged
- [A storage status in which a document is no longer available in this system. ( HL7V3.0 )] (UMLS (HL7) C1548399) =Idea or Concept =Document Storage Status;
DocumentStorage | - 26. PURPLE
- [Any of a group of colors with a hue between that of violet and red. ( NCI )] (UMLS (NCI) C0439542) =Qualitative Concept
|
- 11. Purified Water
- (UMLS (HL7) C0991883) WATER,PURIFIED;
WATER,PURIFIED PREPARATION;
=Pharmacologic Substance; Inorganic Chemical =WATER;
Inactive Ingredient Preparations;
Substance type;
=AQUADERM CREAM;
xylometazoline 1 MG/ML Nasal Solution;
VANICREAM;
Naphazoline 0.5 MG/ML Nasal Solution;
xylometazoline 0.5 MG/ML Nasal Solution;
Diphenhydramine 20 MG/ML / Zinc Oxide 20 MG/ML Topical Lotion;
methylbenzethonium 1 MG/ML Topical Cream;
SALICYLIC ACID 40% OINTMENT(GM);
ALCOHOL 28%/SALICYLIC ACID 0.5% LOTION;
ALCOHOL/GLYCOLIC ACID LOTION;
ALUMINUM ACETATE 1%/CAMPHOR 3%/MENTHOL 0.5%/PHENOL 1% CREAM,TOP;
BENZOIC ACID 12%/SALICYLIC ACID 6% CREAM,TOP;
CARA-KLENZ,SKIN & WOUND CLEANSER;
CARRINGTON INCONTINENCE SKIN KIT;
CHLORHEXIDINE GLUCONATE 0.5%/ISOPROPYL ALCOHOL 70% PAD,TOP;
CLEANSING SHAMPOO;
DIBUCAINE 1% CREAM,TOP;
DIPHENHYDRAMINE 12.5MG/PSEUDOEPHEDRINE 60MG/5ML SYRUP;
HYDROPHILIC OINT,TOP;
MAGNESIUM SALICYLATE 325 MG Oral (systemic) tablet;
MONOBASE CREAM,TOP;
NUSOAP SOAP;
OCUCLENZ OPH,IRRG;
RAYNOX CREAM;
ROSE WATER OINT,TOP;
SKIN CREAM,TOP;
SULFUR 5% SHAMPOO;
SULFUR 5%/SULFURATED POTASH/ZINC OXIDE 10% CREAM,TOP;
UNDECYLENIC ACID 5%/ZINC UNDECYLENATE 20% CREAM,TOP;
VITAMIN E 14% CREAM,TOP;
WATER,PURIFIED 85 % | - 27. Purpose
- [What something is used for; reason or intention. ( NCI )] (UMLS (NCI) C1285529) =Functional Concept
|
- 12. Purimethol
- (UMLS (NCI) C0917847) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 28. purpura
- [small hemorrhage in the skin, mucous membrane or serosal surface, or a group of hemorrhagic diseases characterized by purpuric lesions. ( CSP )] (UMLS (CSP) C0034150) =Disease or Syndrome ;
=blood coagulation disorder;
HEMORRHAGIC COND NOS;
Skin Manifestations;
=Purpura, Thrombocytopenic;
Purpura, Hyperglobulinemic;
ALLERGIC PURPURA;
Purpura, Thrombocytopenic |
- 13. purine
- [bicyclic ring structure consisting of fused imidazole and pyrimidine rings, with nitrogen atoms at the 1,3,7, and 9 positions; the basic structure of adenine, guanine, and other biologically important bases. ( CSP )] (UMLS (CSP) C0034140) =Organic Chemical ;
=2-Ring Heterocyclic Compound;
nitrogenous heterocyclic compound =2-Aminopurine;
methylpurine;
oxypurine;
1,7-Dihydro-6H-purine-6-thione;
1H-Purin-6-amine;
1,5-Dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one;
Purinones;
2-Amino 6MP | - 29. Purpura and other hemorrhagic conditions
- [ ] (UMLS (ICD9CM) C0154300) =Disease or Syndrome
|
- 14. purine analog
- [synthetic or natural chemical compounds which resemble naturally occurring purine in structure and/or function. ( CSP )] (UMLS (CSP) C1268902) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=nucleobase analog;
=adenine analog;
azapurine;
guanine analog;
thiopurine;
xanthine analog;
| - 30. Purpura/coagulation defects/abnormal platelets
- (UMLS (ICPC) C0497166) (Purpura/coagulation defects/abnormal platelets; PURPURA/KOAGULAZIO AKATSA/PLAKETA ANORMALAK; Purpura/koag def/unorm blodplader; Purpura/stollingsst/afw thromb; PURPPURA/ HYYTYMISHAIRIOT/ POIKKEAVAT VERIHIUTALEET; Purpura/defaut coag/plaq anorm; Purpura/Gerinnungs-/Thrombozyt-Stoer; purpura/beayot bikrisha; purpura/alvadasi/verlemezke zavar; Porpora/difetti coag/piastrine an; PURPURA/KOAGUL.DEF/UNORMAL BLODPL; Purpura/defice coagul/plaq anormal; Purpura/coagulopatias/plq an; PURPURA/KOAG DEFEKT/AVVIKANDE TROMBOCYTER) Purpura/coag defects/abn plate =Disease or Syndrome =BLOOD, BLOOD FORMING ORGANS, LYMPHATICS, SPLEEN; Diagnosis/Diseases Component
|
- 15. Purine Antagonist
- [Class of drugs that affect the metabolism and utilization of purines. ( NCI )] (UMLS (NCI) C0280038) =Pharmacologic Substance
| - 31. pursuit tracking
- [ ] (UMLS (CSP) C0599242) =Physiologic Function ;
|
- 16. purine metabolism
- [ ] (UMLS (CSP) C1621315) =Molecular Function
| - 32. PURULENT ENDOPHTHALM NOS
- [ ] (UMLS (ICD9CM) C0259800) =Disease or Syndrome
|
home
